Acarbose

Chinese adults with type 2 diabetes achieved a 0.93% HbA1c reduction with 24 weeks of mulberry twig alkaloid therapy, an outcome comparable with use of the alpha-glucosidase inhibitor acarbose, according to data published in Diabetes Care.